BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 9566711)

  • 1. Restriction fragment length polymorphism of the L-myc oncogene in non-Hodgkin's lymphoma patients from India.
    Fernandez T; Saranath D; Advani SH; Deo MG; Soman CS
    Cancer Lett; 1998 Mar; 125(1-2):165-9. PubMed ID: 9566711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased frequency of the S allele of the L-myc oncogene in non-Hodgkin's lymphoma.
    Crossen PE; Morrison MJ; Colls BM
    Br J Cancer; 1994 Apr; 69(4):759-61. PubMed ID: 7908219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is there any correlation between restriction fragment length polymorphism of the L-MYC gene and metastasis of human nonsmall cell lung cancer?
    Yaylim I; Isbir T; Oztürk O; Turna A; Işitmangil T; Zonüzi F; Camlica H
    Cancer Genet Cytogenet; 2002 Apr; 134(2):118-22. PubMed ID: 12034523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Close correlation between restriction fragment length polymorphism of L-myc gene and susceptibility to gastric cancer.
    Isbir T; Yaylim I; Arikan S; Kaytan E; Karşidağ T; Bayrak S; Camlica H
    Cancer Detect Prev; 2002; 26(6):454-7. PubMed ID: 12507230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EcoRI polymorphism of the L-myc gene in gastric cancer patients.
    Dlugosz A; Adler G; Ciechanowicz A; Jaroszewicz-Heigelmann H; Starzynska T
    Eur J Gastroenterol Hepatol; 2002 Nov; 14(11):1231-5. PubMed ID: 12439118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated frequency of a SstI polymorphism of the Ets-1 oncogene in non-Hodgkin's lymphoma patients.
    Crossen PE; Morrison MJ; Colls BM
    Cancer Genet Cytogenet; 1995 Jan; 79(1):70-3. PubMed ID: 7850755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Restriction fragment length polymorphism of the L-myc gene in oral cancer patients.
    Saranath D; Panchal RG; Nair R; Mehta AR; Sanghavi V; Deo MG
    Br J Cancer; 1990 Apr; 61(4):530-3. PubMed ID: 1970484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The EcoRI RFLP of c-mos in patients with non-Hodgkin's lymphoma and acute lymphoblastic leukemia, compared to geriatric and non-geriatric controls.
    Chenevix-Trench G; Southall M; Kidson C
    Int J Cancer; 1989 Jun; 43(6):1034-6. PubMed ID: 2567285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between restriction fragment length polymorphism of the L-myc gene and susceptibility to gastric cancer.
    Shibuta K; Mori M; Haraguchi M; Yoshikawa K; Ueo H; Akiyoshi T
    Br J Surg; 1998 May; 85(5):681-4. PubMed ID: 9635822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences of L-myc polymorphic patterns of neuroblastoma in patients under 1 year versus older ages: a preliminary report.
    Murakami T; Ohmori H; Katoh T; Nakamura H; Tsuda T; Shan RC; Akiya S; Nakagawara A; Higashi K
    J Pediatr Surg; 1992 Nov; 27(11):1442-6. PubMed ID: 1362216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased frequency of the S-allele of the L-myc oncogene in breast cancer.
    Isbir T; Yaylim I; Arîkan S; Küçücük S; Camlíca H
    Mol Med; 2002 Sep; 8(9):521-4. PubMed ID: 12456990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of the SS genotype of the L-myc gene and loss of 18q sequences with a worse clinical prognosis in colorectal cancers.
    Young J; Buttenshaw R; Butterworth L; Ward M; Searle J; Leggett B; Chenevix-Trench G
    Oncogene; 1994 Apr; 9(4):1053-6. PubMed ID: 7907781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between matrix metalloproteinase 2 (MMP2) promoter polymorphisms and the susceptibility to non-Hodgkin's lymphoma in Egyptians.
    Gouda HM; Khorshied MM; El Sissy MH; Shaheen IA; Mohsen MM
    Ann Hematol; 2014 Aug; 93(8):1313-8. PubMed ID: 24627195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Restriction fragment length polymorphisms of the human N-myc gene in normal healthy individuals and oral cancer patients in India.
    Saranath D; Panchal RG; Deo MG; Sanghvi V; Mehta AR
    Indian J Biochem Biophys; 1994 Jun; 31(3):177-83. PubMed ID: 7959843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allelic variation of the c-raf-1 oncogene in non-Hodgkin's lymphoma.
    Chenevix-Trench G; Behm F; Westin E
    Leukemia; 1987 Jan; 1(1):82-6. PubMed ID: 2889852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Restriction fragment length polymorphism of the L-myc gene is not a prognostic factor in bladder cancer patients.
    Ejarque MJ; Vicente M; Bernués M; Oliver A; Vicente J; Capellá G; Lluís F; Chéchile G
    Br J Cancer; 1999 Apr; 79(11-12):1855-8. PubMed ID: 10206304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. L-myc restriction fragment length polymorphism in Japanese patients with esophageal cancer.
    Shibuta K; Inoue H; Sato K; Matsuyama A; Ueo H; Tanaka Y; Mafune K; Barnard GF; Mori M
    Jpn J Cancer Res; 2000 Feb; 91(2):199-203. PubMed ID: 10761707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Restriction fragment length polymorphism of the L-myc gene and susceptibility to metastasis in renal cancer patients.
    Kakehi Y; Yoshida O
    Int J Cancer; 1989 Mar; 43(3):391-4. PubMed ID: 2564378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Restriction fragment length polymorphisms of L-myc and myb in human leukaemia and lymphoma in relation to age-selected controls.
    Chenevix-Trench G; Southall M; Kidson C
    Br J Cancer; 1989 Dec; 60(6):872-4. PubMed ID: 2574989
    [No Abstract]   [Full Text] [Related]  

  • 20. c-Myc oncogene and Cdc25A cell activating phosphatase expression in non-Hodgkin's lymphoma.
    Aref S; Fouda M; El-Dosoky E; Menessy A; Mabed M; Saleeb M; Zalata K
    Hematology; 2003 Jun; 8(3):183-90. PubMed ID: 12745652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.